BIOMEX GmbH, Europe’s leading provider of human biospecimens and services for the diagnostics industry, announced today the acquisition of Atreide Biosamples in an asset deal.
Based in Hannover, Germany, Atreide Biosamples is an expert in the sourcing of human biological samples and clinical information, specializing, among other things, in the sourcing of human tumor tissue.
“We are very pleased to welcome our new colleagues from Atreide to BIOMEX,” said Oliver Bošnjak, General Manager of BIOMEX. “With this acquisition, we are strengthening and expanding our market presence in the Life Sciences sector and significantly driving market penetration with our offerings and services. With Atreide’s know-how and established network, we are now in a position to serve even complex requests with our expected high quality.”
Dr. Michael Jürgens and his team are looking forward to further cooperation. “In the future, our customers will benefit from the already established infrastructure and the extensive product and service offerings of BIOMEX. With over 50,000 FFPE blocks in inventory, together we can serve our customers’ needs quickly and reliably.”
“With this acquisition, BIOMEX has come a big step closer to its target of being the most comprehensive provider of human samples and a reliable problem solver for the Life Science industry” says Oliver Bošnjak.